Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats

Journal of Pineal Research

Volumn 35, Issue 3, 2003, Pages 212-220

  Cam, Meryem ^a   Yavuz, Özlem ^a   Guven, Aysel ^a   Ercan, Feriha ^b   Bukan, Neslihan ^c   Üstündag, Nil ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

Diabetic renal injury; Glutathione peroxidase; Immunohistochemistry; Malondialdehyde; Melatonin; Oxidative stress; Streptozotocin

Indexed keywords

ANTIOXIDANT; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELATONIN; SOMATOMEDIN C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY HOMOGENATE; KIDNEY INJURY; LIPID PEROXIDATION; LONG TERM CARE; MALE; MORPHOLOGY; NONHUMAN; OXIDATIVE STRESS; RAT; STAINING; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALONDIALDEHYDE; MELATONIN; MICROSCOPY, ELECTRON; OXIDATIVE STRESS; RATS;

EID: 0042412173     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2003.00082.x     Document Type: Article

References (44)

1. BANGSTAD HJ, OSTERBY R, DAHL-JORGENSEN K et al. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; 37:483-490.
2. The Diabetes Control And Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329:977-986.
3. STACKHOUS S, MILLER PI, PARK SK et al. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes 1990; 39:985-995.
4. HA H, KIM KH. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Prac 1999; 45:147-151.
5. DESJARDINS M, BENDAYAN M. Ultrastructural distribution of glomerular basement membrane components in experimental diabetes. Diabetes Res 1990; 14:65-73.
6. SCHLEICHER E, KOLM V, CEOL M, NERLICH A. Structural and functional changes in diabetic glomerulopathy. Kidney Blood Press Res 1996; 19:305-315.
7. MAUER SM, STEFFES MW, ELLIS EN et al. Structural functional relationships in diabetic nephropathy. J Clin Invest 1984; 74:1143-1155.
8. ADLER S. Structure function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 1994; 5:1165-1172.
9. ZIYADEH FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993; 22:736-744.
10. REICHARD P, NEILSSON BY, ROSEUQVIST U. The effect of long term-intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Eng J Med 1993; 329:304-309.
11. AYO SH, RADNIK RA, GLASS WF II et al. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990; 136:1339-1348.
12. RUIZ-MUNOZ LM, VIDAL VF, LAMREABE I. Enaraplilat inhibits hydrogen peroxide production by routine mesangial cells exposed to high glucose concentrations. Nephrol Dial Transplant 1997; 12:456-464.
13. HA H, YOON SJ, KIM KH. High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int 1994; 46:1620-1626.
14. HA H, LEE SH, KIM KH. Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-β and fibronectin, lipid peroxidation induced by high glucose in cultured mesangial cells. J Pharmacol Exp Ther 1997; 28:1462-1497.
15. LARKINS RG, DUNLOP ME. The link between hyperglycemia and diabetic nephropathy. Diabetologia 1992; 35:977-986.
16. NAGAMATSU M, NICKANDER KK, SCHMELZER JD et al. Lipoic acid improves nerve blood flow reduces oxidative stress and improves distal nerve conduction in diabetic neuropathy. Diabetes Care 1995; 18:1160-1167.
17. TING HH, TIMIMI FK, BOLES KS et al. Vitamin C improves endothelium dependent vasodilatation in patient with non-insulin dependent diabetes mellitus. J Clin Invest 1996; 97:22-28.
18. TRACHTMAN H, FUTTREWEIT S, BIENKOWSKI RS. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem Biophys Res Commun 1993; 191:759-765.
19. TRACHTMAN H. VITAMIN E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvas Res 1994; 47:232-239.
20. REITER RJ, TANG L, GARCIA JJ et al. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60:2255-2271.
21. PABLOS MI, AGAPITO MT, GUTIERREZ R et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995; 19:111-115.
22. LEE HB, CHA MK, SONG KI. Pathogenic role of advanced glycosilation end products in diabetic nephropathy. Kidney Int 1997; 52 (Suppl 60):S60-S65.
23. ARMSTRONG D, AL-AWADI F. Lipid peroxidation and retinopathy in streptozotocin induced diabetes. Free Radic Biol Med 1991; 11:433-436.
24. MONTILLA PL, VARGAS JF, TUNEZ IF et al. Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998; 25:94-100.
25. MIHARA M, UCHIAMA M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86:279-286.
26. RAUSCHER FM, SANDERS RA, WATKINS JB. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15:159-164.
27. LOWRY OH. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275.
28. KRISNA MI, DAS UN. Effect of L-arginine-nitric oxide system in chemical induced diabetes mellitus. Free Radic Biol Med 1998; 25:757-765.
29. HA H, YU MR, KIM KH. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 1999; 26:944-950.
30. BAYDAS G, CANATAN H, TURKOGLU A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J Pineal Res 2002; 32:225-230.
31. COOPER ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001; 44:1957-1972.
32. MAKINO H, SUGIYAMA H, KASHIHORA N. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int 2000; 58:S67-S75.
33. VOLKOVOVA K, CHORVATHOVA V, JURCOVICOVA M et al. Antioxidative status of the myocardium and kidneys in acute diabetic rats. Physiol Res 1993; 42:251-255.
34. JANG YY, SONG JH, SHIN YK. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000; 42:361-371.
35. HA H, LEE HB. Reactive oxygen species as glucose signalling molecules in mesangial cells cultured under high glucose. Kidney Int Suppl 2000; 77:S19-25.
36. CATHERWOOD HA, POWELL LA, ANDERSON P et al. Glucose-induced oxidative stress in mesangial cells. Kidney Int 2002; 61:599-608.
37. TAN DX, REITER RJ, MANCHESTER LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad-spectrum antioxidant and free radical scavenger. Curr Topics Med Chem 2002; 2:181-197.
38. REITER RJ, TAN DX, MANCHESTER LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001; 34:237-256.
39. SENER G, SEHIRLI AO, ALTUNBAS HZ et al. Melatonin protects against gentamicin-induced nephrotoxicity. J Pineal Res 2002; 32:231-236.
40. SAILAJA DEVI MM, SURESH Y, DAS UN. Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 2000; 29:108-115.
41. PARLAKPINAR H, SAHNA E, OZER MK et al. Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. J Pineal Res 2002; 33:161-166.
42. DZIEGIEL P, SUDER E, SUROWIAK P et al. Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 2002; 33:95-100.
43. FLYVBJERG A, LANDAU D, DOMENE H et al. The role of growth hormone, insulin like growth factors (IGFs) and IGF-binding proteins in experimental diabetic kidney disease. Metabolism 1995; 44:67-71.
44. BONNEFONT-ROUSSELOT D, BASTARD JP, JAUDON MC et al. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26:163-176.